EUVIMEDEUVIMED entdecken
Crossref

Efficacy of Hyaluronidase in Treating Calcium Hydroxylapatite-Induced Arterial Occlusion: An Experimental Study Using the Leporine Auricular Artery as a Model

Svetlana Larkina, Oleksandra Seletska, Nina Oliynik, Marianna Lytvynenko, Liliana Sytnyk, Christoper Rowland Payne iD

Facial Plastic Surgery · 30.10.2026

DOI: 10.1055/a-2905-6767 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Facial Plastic Surgery, online erschienen am 30.10.2026. Verfasst von Svetlana Larkina und 5 weiteren Autor:innen. Beteiligte Einrichtung: Devonshire Dermatology, Department of Dermatology, United Kingdom, London. Die Arbeit nennt 7 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyaluronidase “melts” hyaluronic acid (HA); no such antidote exists for calcium hydroxylapatite (CaHA). Experimental evidence demonstrating efficacy of hyaluronidase in treating arterial compromise due to CaHA is lacking. Nevertheless, its use is mentioned in papers describing the management of vascular occlusion due to CaHA. The objective of this study is to investigate the efficacy of hyaluronidase as a treatment for CaHA-induced arterial occlusion using the leporine auricular artery as a model. This is a prospective case–control series. Six Oryctolagi cuniculi were divided into two groups of three, Groups 1 and 2. Right auricular blood flow was examined by Doppler in all six. In all six, the right auricular artery was then occluded by injection of CaHA. Occlusion was confirmed by Doppler. On Day 0, Group 1 received injection of hyaluronidase, Group 2 did not. In each group, one occluded ear was biopsied on Day 1 and another on Day 4. On Day 7, the third occluded ear in each group was examined by Doppler and then biopsied. Doppler demonstrated that without hyaluronidase blood flow rate at Day 7 was only 10% of the pre-occlusion flow rate, whereas with hyaluronidase blood flow rate at Day 7 was considerably recovered at 58% of the pre-occlusion rate. Histology revealed a similar story: without hyaluronidase at Day 7 the arterial wall anatomy was largely destroyed, whereas with hyaluronidase the arterial wall anatomy was largely conserved. Hyaluronidase improves tissue viability after arterial occlusion by CaHA. This finding has important implications for patient care.

Autor:innen und Institutionen

  • Devonshire Dermatology, Department of Dermatology, United Kingdom, London.
  • Anglia Ruskin University, United Kingdom, Chelmsford.
  • Cytology, Embryology and Pathological Morphology with a Course in Forensic Medicine, Odesa National Medical University, Department of Histology, Ukraine, Odesa.
  • The London Clinic, UK, London.

ORCID-Profile: Christoper Rowland Payne

Zitieren

APA

Larkina, S., Seletska, O., Oliynik, N., Lytvynenko, M., Sytnyk, L., & Rowland Payne, C. (2026). Efficacy of Hyaluronidase in Treating Calcium Hydroxylapatite-Induced Arterial Occlusion: An Experimental Study Using the Leporine Auricular Artery as a Model. Facial Plastic Surgery. https://doi.org/10.1055/a-2905-6767

Vancouver

Larkina S, Seletska O, Oliynik N, Lytvynenko M, Sytnyk L, Rowland Payne C. Efficacy of Hyaluronidase in Treating Calcium Hydroxylapatite-Induced Arterial Occlusion: An Experimental Study Using the Leporine Auricular Artery as a Model. Facial Plastic Surgery. 2026. doi:10.1055/a-2905-6767

BibTeX
@article{Larkina2026,
  author = {Larkina, Svetlana and Seletska, Oleksandra and Oliynik, Nina and Lytvynenko, Marianna and Sytnyk, Liliana and Rowland Payne, Christoper},
  title = {Efficacy of Hyaluronidase in Treating Calcium Hydroxylapatite-Induced Arterial Occlusion: An Experimental Study Using the Leporine Auricular Artery as a Model},
  journal = {Facial Plastic Surgery},
  year = {2026},
  doi = {10.1055/a-2905-6767}
}
Kostenlos starten →